The two medications belong to entirely different drug classes, work through completely separate mechanisms, and produce different clinical outcomes
These strategies compared to currently available drug medications such as thiazolidinediones, sulphonylureas, and insulin, have the potential to treat diabetes without causing side effects of hypoglycemia and weight gain
Thus, drugs that mimic the action of GLP-1, known generally as GLP-1 receptor agonists, are widely used in the management of T2D and obesity, which as outlined above are both closely linked to CKD
Watch now on iPlayer Wegovy's manufacturer, Novo Nordisk, said that treatment decisions should be made together with a healthcare provider and that "side effects should be taken into account as part of this"
Are Pendulum probiotics safe